Suppr超能文献

瑞芬太尼 2μg/kg 和丙泊酚 2mg/kg 后罗库溴铵用于快速气管插管的剂量。

Dose of rocuronium for rapid tracheal intubation following remifentanil 2 μg kg-1 and propofol 2 mg kg-1.

机构信息

Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

出版信息

Eur J Anaesthesiol. 2013 Sep;30(9):550-5. doi: 10.1097/EJA.0b013e3283622ba0.

Abstract

CONTEXT

Full relaxation is not mandatory for successful tracheal intubation.

OBJECTIVE

We tried to find the dose of rocuronium that gave acceptable intubation conditions in a rapid sequence intubation with remifentanil and propofol.

DESIGN

A dose-finding study of rocuronium using a modified Dixon's up-and-down method.

SETTING

A single tertiary care teaching hospital.

PARTICIPANTS

Patients undergoing elective surgery under general anaesthesia.

INTERVENTIONS

After premedication with midazolam and glycopyrrolate, anaesthesia was induced using remifentanil 2 μg kg and propofol 2 mg kg, and a predetermined dose of rocuronium was administered. The dose of rocuronium was determined by a modified Dixon's up-and-down method starting from 0.8 mg kg with an interval of 0.1 or 0.05 mg kg. Intubation was performed 60 s after the start of the rocuronium injection. Intubation conditions were graded as excellent, good or poor. Excellent or good were regarded as clinically acceptable.

MAIN OUTCOME MEASURE

A dose of rocuronium needed for acceptable intubation condition in 50% of patients (ED50) during rapid tracheal intubation after induction of anaesthesia with remifentanil and propofol.

RESULTS

Twenty-eight patients were enrolled to obtain six crossovers. The ED50 of rocuronium was 0.20 mg kg (95% confidence interval, CI 0.17 to 0.23 mg kg) by a modified Dixon's up-and-down method.

CONCLUSION

After induction of anaesthesia with remifentanil 2 μg kg and propofol 2 mg kg, the ED50 of rocuronium for acceptable intubation condition was 0.20 mg kg (95% CI, 0.17 to 0.23 mg kg) for rapid sequence intubation. Thus, we recommend that the intubation dose should be 0.8 mg kg.

TRIAL REGISTRATION

Clinical trial registration KCT0000094.

摘要

背景

完全松弛并非成功气管插管的必要条件。

目的

我们试图在瑞芬太尼和丙泊酚诱导的快速序贯气管插管中找到可接受插管条件的罗库溴铵剂量。

设计

使用改良 Dixon 上下法的罗库溴铵剂量发现研究。

设置

一家三级保健教学医院。

参与者

在全身麻醉下接受择期手术的患者。

干预措施

在咪达唑仑和格隆溴铵预处理后,使用瑞芬太尼 2μg/kg 和丙泊酚 2mg/kg 诱导麻醉,并给予预定剂量的罗库溴铵。罗库溴铵的剂量通过改良 Dixon 上下法确定,起始剂量为 0.8mg/kg,间隔 0.1 或 0.05mg/kg。罗库溴铵注射开始后 60s 进行插管。插管条件分为优秀、良好或差。优秀或良好被认为是临床可接受的。

主要观察指标

瑞芬太尼和丙泊酚诱导麻醉后快速气管插管时 50%患者可接受插管条件的罗库溴铵剂量(ED50)。

结果

纳入 28 例患者进行 6 次交叉。改良 Dixon 上下法得出罗库溴铵的 ED50 为 0.20mg/kg(95%置信区间,0.17 至 0.23mg/kg)。

结论

瑞芬太尼 2μg/kg 和丙泊酚 2mg/kg 诱导麻醉后,罗库溴铵用于快速序贯插管可接受插管条件的 ED50 为 0.20mg/kg(95%置信区间,0.17 至 0.23mg/kg)。因此,我们建议插管剂量应为 0.8mg/kg。

试验注册

临床试验注册号 KCT0000094。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验